The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons.
It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.
Hepatitis B and C epidemiology in selected population groups in the EU/EEA
Download
This report details the findings of a comparative analysis of existing hepatitis B/C testing guidelines and available data on the prevalence and incidence of HBV and HCV among at-risk population groups in EU/EEA countries, to outline the key at-risk groups for hepatitis B and C in EU and EEA countires.
